J&J Aims to Achieve 1 Billion Covid Vaccines, CFO Says

Jul.16 — Johnson & Johnson Chief Financial Officer Joseph Wolk says the company is in active discussions with the European Union, Japan and the Bill & Melinda Gates Foundation to determine how much supply of its experimental coronavirus vaccine will be needed. He speaks with Bloomberg’s Alix Steel and Guy Johnson on “Bloomberg Markets.”

Leave a Comment